Top Story

Michael H. Davidson, MD, discusses PCSK9 as a target of therapy

October 24, 2014

BOSTON — In this video, Cardiology Today Editorial Board member Michael H. Davidson, MD, outlines a session he participated in at the Cardiometabolic Health Congress on PCSK9 as a target for cholesterol-lowering therapy.

Davidson, clinical professor of medicine and director of the lipid clinic at the University of Chicago Pritzker School of Medicine, noted that in less than a decade since discovering that PCSK9 deficiencies led to reduced LDL cholesterol and CV risk, multiple clinical trials have indicated the effectiveness of PCSK9 as an LDL-lowering therapy. He also addressed the lowering of LDL as a target of therapy, and acknowledged that several outcome trials assessing this possibility are currently underway.

figure Meeting News CoverageVideo

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014
BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed primarily at diabetes or metabolic disease poses…
figure Meeting News Coverage

Efficacy, safety of aspirin for treatment of patients with diabetes, CAD unclear

October 24, 2014
BOSTON — The benefits of using aspirin, alone or with a platelet inhibitor, for the treatment of patients with diabetes at high-risk for CVD are still unclear…
figure Meeting News Coverage

Expert examines contribution of aldosterone in obesity-related hypertension

October 24, 2014
BOSTON — At the Cardiometabolic Health Congress, Colleen M. Majewski, MD, discussed the link between elevated aldosterone and obesity-related hypertension, and…
More News Headlines »
Editorial
figure

Achievement of target LDL particle number leads to fewer CV events

Endocrine Today, September 2014
James A. Underberg, MS, MD, FACP, FACPM, FNLA
For decades, clinicians have relied on cholesterol-based measures of LDL to predict and manage their patients’ risk for…
More »
Blog

Plasmaphoresis — Yes or No?

January 7, 2014
It is no secret that I am a “bone head,” literally and figuratively, but from time to time, I encounter…
More »
Meeting News Coverage Video
figure

Michael H. Davidson, MD, discusses PCSK9 as a target of therapy

October 24, 2014
BOSTON — In this video, Cardiology Today Editorial Board member Michael H. Davidson, MD, outlines a session he…
More »